Cell And Gene Therapy: The Starring Role Of Stirred Tank Bioreactors

The field of cell and gene therapy has enjoyed spectacular growth in recent years and is destined to be one of the strongest growing markets in the biopharmaceutical industry. More than 20 approved gene therapies are already on the market, providing potentially life-saving treatment options for patients with rare diseases. Manufacturing these novel therapies requires a continual supply of billions of cells, generated by robust, scalable, and economically viable bioprocesses.

In this regard, stirred-tank bioreactors have emerged as the optimal platform to optimize (stem) cell culturing to optimize process development. While facing similar challenges as encountered by the traditional biologics industry, the cell and gene therapy industry can benefit from those lessons. This community will benefit from the successful transfer of knowledge and best practices in terms of scalability, single-use technologies, and the overall benefits of moving to stirred-tank bioreactor systems. In this webinar, experts from industry and academia will share their insights and experiences as they lay out the potential of stirred-tank bioreactors for cell and gene therapy development and manufacturing.

Viewers will learn:

• Advances in commercializing cell and gene therapy development
• The key role of stirred-tank bioreactors from research to manufacturing
• How to bring life-saving cell and gene therapies to market